Transamerica Financial Advisors »

Alnylam Pharmaceuticals shares owned by Transamerica Financial Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Transamerica Financial Advisors from 13F filings

Historical chart of Transamerica Financial Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Transamerica Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Transamerica Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.4M 8.6k 397.63
2025-09-30 $35k 77 456.00

More positions owned by Transamerica Financial Advisors

Vanguard Index Fds Large Cap Etf (VV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
NVIDIA Corporation (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Mid Cap Etf (VO)
Broadcom (AVGO)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Invesco Exchange Traded Fd T Dorsey Wrgt Inds (PRN)
Ishares Tr Core S&p Scp Etf (IJR)
Apple (AAPL)
Amphenol Corp Cl A (APH)
Invesco Exchange Traded Fd T Dorsey Wrgt Tech (PTF)
Ge Vernova (GEV)

View all positions for Transamerica Financial Advisors

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals